Interpretation of"Guidelines for Monitoring and Management of Adverse Reactions Associated with Trastuzumab"issued by the Asia-Pacific Oncology Expert Group
TANG Xueqin
ZHENG Xueyan
WANG Qiaoling
LIU Li
LI Ben
Abstract：This article interpreted"Guidelines for Monitoring and Management of Adverse Reactions Associated with Trastuzumab"issued by the Asia-Pacific Oncology Expert Group in August 2023.It aimed to provide practical suggestions for clinical medical staff to monitor and manage adverse events associated with trastuzumab.
Keywords：breast cancertrastuzumab deruxtecanadverse reactionshuman epidermal growth factor receptor 2targeted therapynursing
Publication Date：2024-11-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 3801-3805 )